Beyond Historical Balance Sheet

DOCKF Stock

USD 0.0001 0.05 99.82%

Trend analysis of Beyond Medical Technologies balance sheet accounts such as Accounts Payable of 139.6 K or Net Receivables of 0.0 provides information on Beyond Medical's total assets, liabilities, and equity, which is the actual value of Beyond Medical Techn to its prevalent stockholders. By breaking down trends over time using Beyond Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Beyond Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

About Beyond Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Beyond Medical Techn at a specified time, usually calculated after every quarter, six months, or one year. Beyond Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Beyond Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Beyond currently owns. An asset can also be divided into two categories, current and non-current.

Beyond Medical Balance Sheet Chart

At this time, Beyond Medical's Net Tangible Assets are most likely to increase significantly in the upcoming years. The Beyond Medical's current Accounts Payable is estimated to increase to about 139.6 K, while Total Current Liabilities is projected to decrease to roughly 332.3 K.

Total Current Liabilities Accounts Payable Total Current Assets Common Stock

Total Current Liabilities

Total Current Liabilities is an item on Beyond Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Beyond Medical Technologies are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Beyond Medical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Beyond Medical Techn are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Most accounts from Beyond Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Beyond Medical Techn current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Beyond Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

	2024	2025 (projected)
Common Stock	27.1M	17.0M
Total Current Assets	86.1K	81.8K

Common Stock Total Current Assets

Beyond Medical balance sheet Correlations

	Total Current Liabilities	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Total Current Assets	Common Stock	Property Plant Equipment	Total Assets	Other Current Liab	Total Stockholder Equity	Cash	Non Current Assets Total	Other Assets	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Net Invested Capital	Net Working Capital	Short Term Investments	Capital Stock	Property Plant And Equipment Net	Capital Lease Obligations	Property Plant And Equipment Gross
Total Current Liabilities		-0.67	0.1	0.29	-0.68	-0.75	-0.18	-0.36	-0.19	0.57	-0.18	-0.09	-0.28	0.04	-0.21	0.13	0.49	0.09	0.15	-0.18	-0.16	0.04	0.33	-0.36	-0.3	0.24
Net Tangible Assets	-0.67		-0.36	0.18	0.81	0.93	0.51	0.74	0.11	-0.31	0.09	-0.21	0.52	-0.06	0.07	-0.48	-0.27	0.3	0.27	0.09	0.01	-0.13	0.03	-0.04	-0.04	0.02
Retained Earnings	0.1	-0.36		-0.07	0.02	-0.13	-0.96	-0.09	0.86	-0.35	0.87	0.96	0.42	0.91	0.08	0.93	-0.65	-0.95	-0.76	0.87	0.91	0.94	-0.86	0.68	0.85	-0.85
Accounts Payable	0.29	0.18	-0.07		0.24	0.13	0.1	0.65	0.16	-0.1	0.14	-0.15	0.56	0.11	0.41	-0.26	0.0	0.2	0.15	0.14	0.05	0.03	0.04	0.14	0.02	0.15
Net Receivables	-0.68	0.81	0.02	0.24		0.88	0.17	0.86	0.48	-0.69	0.46	0.15	0.78	0.19	0.27	-0.24	-0.64	-0.01	-0.02	0.46	0.38	0.14	-0.38	0.4	0.42	-0.35
Total Current Assets	-0.75	0.93	-0.13	0.13	0.88		0.32	0.73	0.36	-0.41	0.34	0.06	0.63	0.13	0.32	-0.26	-0.44	0.07	0.01	0.34	0.27	0.07	-0.23	0.23	0.26	-0.24
Common Stock	-0.18	0.51	-0.96	0.1	0.17	0.32		0.25	-0.73	0.25	-0.75	-0.9	-0.26	-0.83	-0.04	-0.94	0.58	0.95	0.78	-0.75	-0.8	-0.87	0.81	-0.6	-0.76	0.78
Property Plant Equipment	-0.36	0.74	-0.09	0.65	0.86	0.73	0.25		0.37	-0.6	0.35	-0.05	0.86	0.17	0.25	-0.36	-0.4	0.15	0.11	0.35	0.23	0.09	-0.2	0.31	0.23	-0.11
Total Assets	-0.19	0.11	0.86	0.16	0.48	0.36	-0.73	0.37		-0.53	1.0	0.91	0.79	0.93	0.3	0.69	-0.83	-0.82	-0.72	1.0	0.99	0.92	-0.91	0.75	0.92	-0.91
Other Current Liab	0.57	-0.31	-0.35	-0.1	-0.69	-0.41	0.25	-0.6	-0.53		-0.53	-0.35	-0.66	-0.34	-0.08	-0.14	0.7	0.36	0.31	-0.53	-0.48	-0.32	0.64	-0.76	-0.63	0.43
Total Stockholder Equity	-0.18	0.09	0.87	0.14	0.46	0.34	-0.75	0.35	1.0	-0.53		0.92	0.77	0.93	0.29	0.71	-0.82	-0.83	-0.73	1.0	0.99	0.92	-0.92	0.75	0.93	-0.91
Cash	-0.09	-0.21	0.96	-0.15	0.15	0.06	-0.9	-0.05	0.91	-0.35	0.92		0.46	0.9	0.22	0.91	-0.72	-0.95	-0.83	0.92	0.96	0.93	-0.91	0.7	0.91	-0.93
Non Current Assets Total	-0.28	0.52	0.42	0.56	0.78	0.63	-0.26	0.86	0.79	-0.66	0.77	0.46		0.65	0.32	0.17	-0.67	-0.36	-0.33	0.77	0.69	0.58	-0.62	0.61	0.64	-0.54
Other Assets	0.04	-0.06	0.91	0.11	0.19	0.13	-0.83	0.17	0.93	-0.34	0.93	0.9	0.65		0.08	0.83	-0.65	-0.88	-0.72	0.93	0.93	1.0	-0.82	0.61	0.8	-0.82
Common Stock Shares Outstanding	-0.21	0.07	0.08	0.41	0.27	0.32	-0.04	0.25	0.3	-0.08	0.29	0.22	0.32	0.08		0.02	-0.19	-0.08	-0.31	0.29	0.28	0.07	-0.29	0.49	0.43	-0.24
Other Current Assets	0.13	-0.48	0.93	-0.26	-0.24	-0.26	-0.94	-0.36	0.69	-0.14	0.71	0.91	0.17	0.83	0.02		-0.44	-0.94	-0.78	0.71	0.78	0.88	-0.74	0.57	0.72	-0.73
Other Stockholder Equity	0.49	-0.27	-0.65	0.0	-0.64	-0.44	0.58	-0.4	-0.83	0.7	-0.82	-0.72	-0.67	-0.65	-0.19	-0.44		0.68	0.6	-0.82	-0.82	-0.64	0.88	-0.66	-0.82	0.87
Total Liab	0.09	0.3	-0.95	0.2	-0.01	0.07	0.95	0.15	-0.82	0.36	-0.83	-0.95	-0.36	-0.88	-0.08	-0.94	0.68		0.87	-0.83	-0.88	-0.92	0.9	-0.68	-0.84	0.87
Deferred Long Term Liab	0.15	0.27	-0.76	0.15	-0.02	0.01	0.78	0.11	-0.72	0.31	-0.73	-0.83	-0.33	-0.72	-0.31	-0.78	0.6	0.87		-0.73	-0.77	-0.75	0.86	-0.65	-0.76	0.84
Net Invested Capital	-0.18	0.09	0.87	0.14	0.46	0.34	-0.75	0.35	1.0	-0.53	1.0	0.92	0.77	0.93	0.29	0.71	-0.82	-0.83	-0.73		0.99	0.92	-0.92	0.75	0.92	-0.91
Net Working Capital	-0.16	0.01	0.91	0.05	0.38	0.27	-0.8	0.23	0.99	-0.48	0.99	0.96	0.69	0.93	0.28	0.78	-0.82	-0.88	-0.77	0.99		0.94	-0.93	0.75	0.94	-0.94
Short Term Investments	0.04	-0.13	0.94	0.03	0.14	0.07	-0.87	0.09	0.92	-0.32	0.92	0.93	0.58	1.0	0.07	0.88	-0.64	-0.92	-0.75	0.92	0.94		-0.84	0.62	0.81	-0.84
Capital Stock	0.33	0.03	-0.86	0.04	-0.38	-0.23	0.81	-0.2	-0.91	0.64	-0.92	-0.91	-0.62	-0.82	-0.29	-0.74	0.88	0.9	0.86	-0.92	-0.93	-0.84		-0.85	-0.95	0.93
Property Plant And Equipment Net	-0.36	-0.04	0.68	0.14	0.4	0.23	-0.6	0.31	0.75	-0.76	0.75	0.7	0.61	0.61	0.49	0.57	-0.66	-0.68	-0.65	0.75	0.75	0.62	-0.85		0.91	-0.64
Capital Lease Obligations	-0.3	-0.04	0.85	0.02	0.42	0.26	-0.76	0.23	0.92	-0.63	0.93	0.91	0.64	0.8	0.43	0.72	-0.82	-0.84	-0.76	0.92	0.94	0.81	-0.95	0.91		-0.89
Property Plant And Equipment Gross	0.24	0.02	-0.85	0.15	-0.35	-0.24	0.78	-0.11	-0.91	0.43	-0.91	-0.93	-0.54	-0.82	-0.24	-0.73	0.87	0.87	0.84	-0.91	-0.94	-0.84	0.93	-0.64	-0.89

Click cells to compare fundamentals

Beyond Medical Account Relationship Matchups

Beyond Medical balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Current Liabilities	274.3K	413.3K	346.9K	430.4K	494.9K	332.3K
Net Tangible Assets	8.2M	3.5M	1.5M	1.5M	1.4M	2.7M
Retained Earnings	(22.3M)	(25.3M)	(25.6M)	(26.1M)	(23.5M)	(24.7M)
Accounts Payable	186.8K	174.6K	86.8K	104.1K	119.7K	139.6K
Total Current Assets	1.2M	1.8M	579.3K	95.6K	86.1K	81.8K
Common Stock	18.0M	18.5M	20.8M	23.6M	27.1M	17.0M
Property Plant Equipment	1.6M	409.2K	612.4K	114.5K	131.6K	125.1K
Total Assets	1.8M	2.0M	608.2K	95.6K	86.1K	81.8K
Total Stockholder Equity	1.5M	1.5M	261.2K	(334.7K)	(301.2K)	(286.2K)
Cash	624.2K	1.4M	536.8K	64.1K	57.7K	54.8K
Non Current Assets Total	2.1M	416.7K	649.2K	144.9K	28.9K	0.0
Other Assets	489.9K	7.5K	36.9K	30.5K	27.4K	26.1K
Common Stock Shares Outstanding	39.5M	56.0M	79.1M	7.9M	7.1M	6.8M
Other Current Assets	5.0K	2.8K	30.1K	1.3K	1.2K	1.1K
Other Stockholder Equity	1.8M	1.8M	3.0M	3.2M	3.7M	2.7M
Total Liab	361.9K	413.3K	346.9K	430.4K	494.9K	355.3K
Net Invested Capital	1.5M	1.5M	261.2K	(304.7K)	(274.2K)	(260.5K)
Net Working Capital	920.4K	1.4M	232.4K	(334.7K)	(301.2K)	(286.2K)

Currently Active Assets on Macroaxis

EBR	Centrais Electricas Brasileiras
HE	Hawaiian Electric Industries
VFC	VF Corporation
BVHMF	Vistry Group PLC
S	SentinelOne

When determining whether Beyond Medical Techn is a strong investment it is important to analyze Beyond Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beyond Medical's future performance. For an informed investment choice regarding Beyond Stock, refer to the following important reports:

How To Invest In Beyond

Details

Is Beyond Stock a good investment?

Details

What is Beyond Medical's Net Worth?

Details

Largest Industrial Machinery & Supplies & Components Companies

View

Largest Pollution & Treatment Controls Companies

View

You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beyond Medical. If investors know Beyond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beyond Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.04)

Revenue Per Share

(0)

Quarterly Revenue Growth

(0.92)

Return On Assets

(2.19)

Return On Equity

(1.89)

The market value of Beyond Medical Techn is measured differently than its book value, which is the value of Beyond that is recorded on the company's balance sheet. Investors also form their own opinion of Beyond Medical's value that differs from its market value or its book value, called intrinsic value, which is Beyond Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beyond Medical's market value can be influenced by many factors that don't directly affect Beyond Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Beyond Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beyond Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beyond Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Beyond Historical Balance Sheet

About Beyond Balance Sheet Analysis

Beyond Medical Balance Sheet Chart

Total Current Liabilities

Accounts Payable

Total Current Assets

Beyond Medical balance sheet Correlations

Beyond Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Beyond Medical balance sheet Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Short Term Investments	+ 1.0	Other Assets
Net Working Capital	+ 0.99	Total Assets
Net Working Capital	+ 0.99	Total Stockholder Equity

Common Stock	- 0.96	Retained Earnings
Capital Lease Obligations	- 0.95	Capital Stock
Total Liab	- 0.95	Cash
Total Liab	- 0.95	Retained Earnings
Property Plant And Equipment Gross	- 0.94	Net Working Capital
Total Liab	- 0.94	Other Current Assets